For thediagnosis of cervical cancer, methylation in the promoter region ofWT1 showed a higher specificity (94.3%), sensitivity(79.4%) and positive predictive value (94.7%) than methylation in the promoterregions of NKX6-1 (88.7%, 73.5% and 89.3%) andDBC1 (79.2%, 70.6% and 80.0%). This evidence concerns the gene NKX6-1 and cervical cancer.